Principal Investigator
Folusakin Ayoade
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20210968
Clinical Trial Summary
Pfizer / A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF-07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID-19”
Phase
Phase II/III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Folusakin Ayoade
Phone Number
+1 (240) 3056546
Email
fxa375@miami.edu